TreeWAS – Variant ID: rs17798800

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G57.6 Lesion of plantar nerve	0.000	0.127	0.873
G57 Mononeuropathies of lower limb	0.000	0.266	0.734
G57.8 Other mononeuropathies of lower limb	0.000	0.312	0.688
G57.1 Meralgia paraesthetica	0.000	0.400	0.600
G57.9 Mononeuropathy of lower limb, unspecified	0.000	0.427	0.573
G57.3 Lesion of lateral popliteal nerve	0.000	0.435	0.565
G57.4 Lesion of medial popliteal nerve	0.000	0.474	0.526
G57.2 Lesion of femoral nerve	0.000	0.474	0.526
G57.5 Tarsal tunnel syndrome	0.000	0.511	0.488
G57.0 Lesion of sciatic nerve	0.000	0.541	0.459
O34.2 Maternal care due to uterine scar from previous surgery	0.407	0.593	0.000
O36.8 Maternal care for other specified foetal problems	0.386	0.614	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.382	0.618	0.000
O36 Maternal care for other known or suspected foetal problems	0.367	0.633	0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.352	0.648	0.000
O36.6 Maternal care for excessive foetal growth	0.315	0.685	0.000
O34.0 Maternal care for congenital malformation of uterus	0.314	0.686	0.000
O40 Polyhydramnios	0.311	0.689	0.000
O34.3 Maternal care for cervical incompetence	0.307	0.693	0.000
O34.5 Maternal care for other abnormalities of gravid uterus	0.302	0.698	0.000
O43 Placental disorders	0.300	0.700	0.000
O36.1 Maternal care for other isoimmunisation	0.297	0.703	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.290	0.710	0.000
O45 Premature separation of placenta [abruptio placentae]	0.284	0.716	0.000
O43.1 Malformation of placenta	0.277	0.723	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.274	0.726	0.000
O34.6 Maternal care for abnormality of vagina	0.274	0.726	0.000
O35 Maternal care for known or suspected foetal abnormality and damage	0.270	0.730	0.000
O34.4 Maternal care for other abnormalities of cervix	0.266	0.734	0.000
O34.7 Maternal care for abnormality of vulva and perineum	0.266	0.734	0.000
O34.1 Maternal care for tumour of corpus uteri	0.265	0.735	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.263	0.737	0.000
O36.2 Maternal care for hydrops foetalis	0.263	0.737	0.000
O36.4 Maternal care for intra-uterine death	0.257	0.743	0.000
O31 Complications specific to multiple gestation	0.252	0.748	0.000
O46 Antepartum haemorrhage, not elsewhere classified	0.248	0.752	0.000
O45.9 Premature separation of placenta, unspecified	0.235	0.765	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.233	0.766	0.000
O36.5 Maternal care for poor foetal growth	0.232	0.768	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.230	0.770	0.000
O43.9 Placental disorder, unspecified	0.226	0.774	0.000
O30 Multiple gestation	0.223	0.777	0.000
O48 Prolonged pregnancy	0.221	0.779	0.000
O36.0 Maternal care for rhesus isoimmunisation	0.220	0.780	0.000
O43.2 Morbidly adherent placenta	0.215	0.785	0.000
O43.0 Placental transfusion syndromes	0.215	0.785	0.000
O41 Other disorders of amniotic fluid and membranes	0.206	0.794	0.000
O45.8 Other premature separation of placenta	0.204	0.796	0.000
O45.0 Premature separation of placenta with coagulation defect	0.204	0.796	0.000
O33 Maternal care for known or suspected disproportion	0.203	0.796	0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.201	0.798	0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.200	0.800	0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.194	0.806	0.000
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.194	0.806	0.000
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.194	0.806	0.000
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.194	0.806	0.000
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.194	0.806	0.000
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.194	0.806	0.000
O44 Placenta praevia	0.185	0.814	0.000
O31.8 Other complications specific to multiple gestation	0.181	0.819	0.000
O31.2 Continuing pregnancy after intra-uterine death of one foetus or more	0.181	0.819	0.000
O31.1 Continuing pregnancy after abortion of one foetus or more	0.181	0.819	0.000
O31.0 Papyraceous foetus	0.181	0.819	0.000
O46.0 Antepartum haemorrhage with coagulation defect	0.178	0.822	0.000
O46.9 Antepartum haemorrhage, unspecified	0.176	0.824	0.000
O46.8 Other antepartum haemorrhage	0.175	0.825	0.000
O36.9 Maternal care for foetal problem, unspecified	0.171	0.829	0.000
O30.9 Multiple gestation, unspecified	0.160	0.840	0.000
O30.8 Other multiple gestation	0.160	0.840	0.000
O30.2 Quadruplet pregnancy	0.160	0.840	0.000
O30.1 Triplet pregnancy	0.160	0.840	0.000
O42 Premature rupture of membranes	0.159	0.841	0.000
O41.9 Disorder of amniotic fluid and membranes, unspecified	0.148	0.852	0.000
O41.1 Infection of amniotic sac and membranes	0.148	0.852	0.000
O33.8 Maternal care for disproportion of other origin	0.146	0.854	0.000
O33.7 Maternal care for disproportion due to other foetal deformities	0.146	0.854	0.000
O33.6 Maternal care for disproportion due to hydrocephalic foetus	0.146	0.854	0.000
O33.5 Maternal care for disproportion due to unusually large foetus	0.146	0.854	0.000
O33.4 Maternal care for disproportion of mixed maternal and foetal origin	0.146	0.854	0.000
O33.3 Maternal care for disproportion due to outlet contraction of pelvis	0.146	0.854	0.000
O33.2 Maternal care for disproportion due to inlet contraction of pelvis	0.146	0.854	0.000
O33.1 Maternal care for disproportion due to generally contracted pelvis	0.146	0.854	0.000
O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones	0.146	0.854	0.000
O43.8 Other placental disorders	0.145	0.855	0.000
O41.8 Other specified disorders of amniotic fluid and membranes	0.140	0.860	0.000
O47 False labour	0.139	0.861	0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.137	0.863	0.000
O30.0 Twin pregnancy	0.130	0.870	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.125	0.875	0.000
O44.1 Placenta praevia with haemorrhage	0.123	0.877	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.118	0.882	0.000
O42.2 Premature rupture of membranes, labour delayed by therapy	0.117	0.883	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.115	0.885	0.000
O32 Maternal care for known or suspected malpresentation of foetus	0.114	0.886	0.000
O41.0 Oligohydramnios	0.113	0.887	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.110	0.890	0.000
O47.9 False labour, unspecified	0.108	0.892	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.104	0.896	0.000
Y52 Agents primarily affecting the cardiovascular system	0.104	0.896	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.102	0.898	0.000
O33.9 Maternal care for disproportion, unspecified	0.097	0.903	0.001
Y42.5 Other oestrogens and progestogens	0.097	0.903	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.094	0.905	0.000
O32.2 Maternal care for transverse and oblique lie	0.092	0.908	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.092	0.908	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.091	0.909	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.091	0.909	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.089	0.911	0.000
O32.0 Maternal care for unstable lie	0.088	0.912	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.087	0.913	0.000
Y48 Anaesthetics and therapeutic gases	0.086	0.913	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.086	0.914	0.000
O44.0 Placenta praevia specified as without haemorrhage	0.085	0.914	0.001
O32.8 Maternal care for other malpresentation of foetus	0.085	0.915	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.084	0.916	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.083	0.917	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.083	0.917	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.083	0.917	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.083	0.917	0.000
Y51.0 Anticholinesterase agents	0.083	0.917	0.000
Y40 Systemic antibiotics	0.083	0.917	0.000
O32.6 Maternal care for compound presentation	0.082	0.918	0.000
Y44 Agents primarily affecting blood constituents	0.082	0.918	0.000
O32.9 Maternal care for malpresentation of foetus, unspecified	0.081	0.919	0.000
Y46.4 Iminostilbenes	0.081	0.919	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.080	0.919	0.000
Y54.5 Other diuretics	0.080	0.919	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.079	0.921	0.000
Y58 Bacterial vaccines	0.079	0.921	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.079	0.921	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.078	0.922	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.078	0.922	0.000
Y40.9 Systemic antibiotic, unspecified	0.077	0.922	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.077	0.923	0.000
Y59 Other and unspecified vaccines and biological substances	0.077	0.923	0.000
O42.9 Premature rupture of membranes, unspecified	0.075	0.924	0.000
Y46.6 Other and unspecified antiepileptics	0.075	0.925	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.075	0.925	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.074	0.926	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.074	0.926	0.000
Y52.7 Peripheral vasodilators	0.074	0.926	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.074	0.926	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.074	0.926	0.000
Y42.9 Other and unspecified hormone antagonists	0.073	0.926	0.000
Y42.4 Oral contraceptives	0.073	0.926	0.000
Y42.2 Antithyroid drugs	0.073	0.926	0.000
Y42.1 Thyroid hormones and substitutes	0.073	0.926	0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.073	0.927	0.000
Y43 Primarily systemic agents	0.072	0.928	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.071	0.929	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.071	0.929	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.071	0.929	0.000
Y54.7 Agents affecting calcification	0.070	0.930	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.069	0.930	0.000
Y54.8 Agents affecting uric acid metabolism	0.069	0.931	0.000
Y48.3 Local anaesthetics	0.067	0.933	0.000
Y48.4 Anaesthetic, unspecified	0.066	0.934	0.000
Y46.8 Antispasticity drugs	0.066	0.934	0.000
Y46.7 Anti-Parkinsonism drugs	0.066	0.934	0.000
Y46.5 Valproic acid	0.066	0.934	0.000
Y46.3 Deoxybarbiturates	0.066	0.934	0.000
Y46.1 Oxazolidinediones	0.066	0.934	0.000
Y46.0 Succinimides	0.066	0.934	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.066	0.934	0.000
Y41.0 Sulphonamides	0.066	0.934	0.000
Y40.4 Tetracyclines	0.065	0.935	0.000
Y54.9 Mineral salts, not elsewhere classified	0.065	0.935	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.065	0.935	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.065	0.935	0.000
Y54.0 Mineralocorticoids	0.065	0.935	0.000
Y53.4 Other laxatives	0.064	0.936	0.000
Y41.5 Antiviral drugs	0.063	0.937	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.063	0.937	0.000
Y54.4 Loop [high-ceiling] diuretics	0.063	0.937	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.062	0.938	0.000
Y48.5 Therapeutic gases	0.062	0.938	0.000
Y48.2 Other and unspecified general anaesthetics	0.062	0.938	0.000
Y48.1 Parenteral anaesthetics	0.062	0.938	0.000
Y48.0 Inhaled anaesthetics	0.062	0.938	0.000
Y43.1 Antineoplastic antimetabolites	0.061	0.939	0.000
Y42.7 Androgens and anabolic congeners	0.061	0.939	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.060	0.939	0.000
Y41.4 Anthelminthics	0.060	0.939	0.000
Y41.3 Other antiprotozoal drugs	0.060	0.939	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.060	0.939	0.000
Y41.1 Antimycobacterial drugs	0.060	0.939	0.000
Y40.7 Antifungal antibiotics, systemically used	0.059	0.941	0.000
Y40.6 Rifamycins	0.059	0.941	0.000
Y40.5 Aminoglycosides	0.059	0.941	0.000
Y40.2 Chloramphenicol group	0.059	0.941	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.059	0.941	0.000
Y44.7 Plasma substitutes	0.059	0.941	0.000
Y44.6 Natural blood and blood products	0.059	0.941	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.059	0.941	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.059	0.941	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.059	0.941	0.000
Y40.3 Macrolides	0.059	0.941	0.000
Y43.0 Antiallergic and antiemetic drugs	0.059	0.941	0.000
O32.3 Maternal care for face, brow and chin presentation	0.058	0.941	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.058	0.941	0.000
O32.4 Maternal care for high head at term	0.058	0.942	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.058	0.942	0.000
Y53.7 Emetics	0.058	0.942	0.000
Y53.6 Antidiarrhoeal drugs	0.058	0.942	0.000
Y53.5 Digestants	0.058	0.942	0.000
Y53.3 Saline and osmotic laxatives	0.058	0.942	0.000
Y53.2 Stimulant laxatives	0.058	0.942	0.000
Y53.0 Histamine H2-receptor antagonists	0.058	0.942	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.057	0.942	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.057	0.942	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.057	0.943	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.057	0.943	0.000
Y55.5 Anticommon cold drugs	0.057	0.943	0.000
Y55.4 Expectorants	0.057	0.943	0.000
Y55.3 Antitussives	0.057	0.943	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.057	0.943	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.057	0.943	0.000
Y55.0 Oxytocic drugs	0.057	0.943	0.000
Y50.9 Central nervous system stimulant, unspecified	0.057	0.943	0.000
Y50.8 Other central nervous system stimulants	0.057	0.943	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.057	0.943	0.000
Y50.1 Opioid receptor antagonists	0.057	0.943	0.000
Y50.0 Analeptics	0.057	0.943	0.000
Y58.9 Other and unspecified bacterial vaccines	0.057	0.943	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.057	0.943	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.057	0.943	0.000
Y58.5 Diphtheria vaccine	0.057	0.943	0.000
Y58.4 Tetanus vaccine	0.057	0.943	0.000
Y58.3 Plague vaccine	0.057	0.943	0.000
Y58.2 Cholera vaccine	0.057	0.943	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.057	0.943	0.000
Y58.0 BCG vaccine	0.057	0.943	0.000
Y45.0 Opioids and related analgesics	0.057	0.943	0.000
Y56.9 Topical agent, unspecified	0.056	0.944	0.000
Y56.8 Other topical agents	0.056	0.944	0.000
Y56.7 Dental drugs, topically applied	0.056	0.944	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.056	0.944	0.000
Y56.5 Ophthalmological drugs and preparations	0.056	0.944	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.056	0.944	0.000
Y56.3 Emollients, demulcents and protectants	0.056	0.944	0.000
Y56.2 Local astringents and local detergents	0.056	0.944	0.000
Y56.1 Antipruritics	0.056	0.944	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.056	0.944	0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.056	0.944	0.000
Y59.9 Vaccine or biological substance, unspecified	0.055	0.944	0.000
Y59.8 Other specified vaccines and biological substances	0.055	0.944	0.000
Y59.2 Protozoal vaccines	0.055	0.944	0.000
Y59.1 Rickettsial vaccines	0.055	0.944	0.000
Y59.0 Viral vaccines	0.055	0.944	0.000
O47.0 False labour before 37 completed weeks of gestation	0.055	0.945	0.000
Y59.3 Immunoglobulin	0.054	0.946	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.054	0.946	0.000
Y54.3 Benzothiadiazine derivatives	0.054	0.946	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.053	0.947	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.053	0.947	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.053	0.947	0.000
Y47.4 Bromine compounds	0.053	0.947	0.000
Y47.3 Paraldehyde	0.053	0.947	0.000
Y47.2 Chloral derivatives	0.053	0.947	0.000
Y47.0 Barbiturates, not elsewhere classified	0.053	0.947	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.052	0.947	0.000
Y45.5 4-Aminophenol derivatives	0.052	0.948	0.000
Y40.8 Other systemic antibiotics	0.052	0.948	0.000
Y43.9 Primarily systemic agent, unspecified	0.051	0.948	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.051	0.948	0.000
Y43.6 Enzymes, not elsewhere classified	0.051	0.948	0.000
Y43.5 Acidifying and alkalising agents	0.051	0.948	0.000
Y43.2 Antineoplastic natural products	0.051	0.948	0.000
Y44.2 Anticoagulants	0.051	0.949	0.000
Y45.4 Antirheumatics	0.051	0.949	0.000
Y45.8 Other analgesics and antipyretics	0.051	0.949	0.000
Y44.5 Thrombolytic drugs	0.051	0.949	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.050	0.950	0.000
Y52.1 Calcium-channel blockers	0.050	0.950	0.000
Y49.9 Psychotropic drug, unspecified	0.050	0.950	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.050	0.950	0.000
Y49.7 Psychostimulants with abuse potential	0.050	0.950	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.050	0.950	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.050	0.950	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.050	0.950	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.050	0.950	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.049	0.951	0.000
Y47.1 Benzodiazepines	0.049	0.951	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.048	0.952	0.000
Y49.2 Other and unspecified antidepressants	0.048	0.952	0.000
Y46.2 Hydantoin derivatives	0.048	0.952	0.000
Y45.2 Propionic acid derivatives	0.047	0.953	0.000
Y43.4 Immunosuppressive agents	0.047	0.953	0.000
Y49.5 Other antipsychotics and neuroleptics	0.045	0.954	0.000
Y40.0 Penicillins	0.044	0.956	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.958	0.042
Y57 Other and unspecified drugs and medicaments	0.041	0.959	0.001
Y40.1 Cefalosporins and other -lactam antibiotics	0.034	0.965	0.000
O32.1 Maternal care for breech presentation	0.033	0.967	0.000
Y57.8 Other drugs and medicaments	0.031	0.969	0.000
Y57.6 Other diagnostic agents	0.030	0.969	0.001
I24 Other acute ischaemic heart diseases	0.000	0.970	0.030
Y57.7 Vitamins, not elsewhere classified	0.029	0.970	0.001
Y57.4 Pharmaceutical excipients	0.029	0.970	0.001
Y57.3 Alcohol deterrents	0.029	0.970	0.001
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.029	0.970	0.001
Y57.1 Lipotropic drugs	0.029	0.970	0.001
Y57.0 Appetite depressants [anorectics]	0.029	0.970	0.001
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.971	0.029
Y45.1 Salicylates	0.028	0.971	0.000
W19.3 Sports and athletics area	0.023	0.977	0.000
I24.1 Dressler's syndrome	0.000	0.978	0.022
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.981	0.019
Y57.9 Drug or medicament, unspecified	0.018	0.982	0.001
W19 Unspecified fall	0.016	0.984	0.000
W19.4 Street and highway	0.015	0.985	0.000
G61.8 Other inflammatory polyneuropathies	0.000	0.987	0.013
Y57.5 X-ray contrast media	0.011	0.987	0.002
H95.1 Other disorders following mastoidectomy	0.013	0.987	0.000
W19.9 Unspecified place	0.012	0.988	0.000
W19.8 Other specified place	0.012	0.988	0.000
W19.5 Trade and service area	0.012	0.988	0.000
W19.0 Home	0.012	0.988	0.000
W19.7 Farm	0.012	0.988	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.011	0.989	0.000
W19.6 Industrial and construction area	0.011	0.989	0.000
G50-G59 Nerve, nerve root and plexus disorders	0.000	0.989	0.011
W19.2 School, other institution and public administrative area	0.011	0.989	0.000
W00-W19 Falls	0.011	0.989	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.010	0.990	0.000
G61 Inflammatory polyneuropathy	0.000	0.990	0.010
R30.0 Dysuria	0.010	0.990	0.000
G61.0 Guillain-Barre syndrome	0.000	0.990	0.010
W19.1 Residential institution	0.009	0.990	0.000
I67.1 Cerebral aneurysm, nonruptured	0.000	0.990	0.010
W03 Other fall on same level due to collision with, or pushing by, another person	0.009	0.991	0.000
H92 Otalgia and effusion of ear	0.009	0.991	0.000
G53 Cranial nerve disorders in diseases classified elsewhere	0.000	0.991	0.009
Chapter XX External causes of morbidity and mortality	0.009	0.991	0.000
H92.1 Otorrhoea	0.009	0.991	0.000
W19.09 Unspecified fall; Home; During unspecified activity	0.009	0.991	0.000
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.009	0.991	0.000
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.009	0.991	0.000
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.009	0.991	0.000
S22.30 Fracture of rib (closed)	0.000	0.991	0.009
M90.78 Fracture of bone in neoplastic disease (Other)	0.009	0.991	0.000
W00 Fall on same level involving ice and snow	0.009	0.991	0.000
W03.0 Home	0.009	0.991	0.000
W08 Fall involving other furniture	0.008	0.991	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.008	0.992	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.008	0.992	0.000
H90-H95 Other disorders of ear	0.008	0.992	0.000
W06 Fall involving bed	0.008	0.992	0.000
G59 Mononeuropathy in diseases classified elsewhere	0.000	0.992	0.008
H92.0 Otalgia	0.008	0.992	0.000
Y10-Y34 Event of undetermined intent	0.008	0.992	0.000
G53.0 Postzoster neuralgia	0.000	0.992	0.008
H92.2 Otorrhagia	0.008	0.992	0.000
G58 Other mononeuropathies	0.000	0.992	0.008
W15 Fall from cliff	0.008	0.992	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.008	0.992	0.000
W12 Fall on and from scaffolding	0.008	0.992	0.000
W09 Fall involving playground equipment	0.008	0.992	0.000
W04 Fall while being carried or supported by other persons	0.008	0.992	0.000
M90.7 Fracture of bone in neoplastic disease	0.008	0.992	0.000
G52 Disorders of other cranial nerves	0.000	0.992	0.008
W05 Fall involving wheelchair	0.008	0.992	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.000	0.992	0.008
G61.1 Serum neuropathy	0.000	0.992	0.008
M89.9 Disorder of bone, unspecified	0.008	0.992	0.000
W07 Fall involving chair	0.007	0.992	0.000
M89 Other disorders of bone	0.007	0.992	0.000
W14 Fall from tree	0.007	0.993	0.000
V70-V79 Bus occupant injured in transport accident	0.007	0.993	0.000
W00.3 Sports and athletics area	0.007	0.993	0.000
M89.98 Disorder of bone, unspecified (Other)	0.007	0.993	0.000
W11 Fall on and from ladder	0.007	0.993	0.000
Y00-Y09 Assault	0.007	0.993	0.000
X10-X19 Contact with heat and hot substances	0.007	0.993	0.000
H90 Conductive and sensorineural hearing loss	0.007	0.993	0.000
Y28 Contact with sharp object, undetermined intent	0.007	0.993	0.000
V90-V94 Water transport accidents	0.007	0.993	0.000
X60-X84 Intentional self-harm	0.007	0.993	0.000
M90 Osteopathies in diseases classified elsewhere	0.007	0.993	0.000
G58.7 Mononeuritis multiplex	0.000	0.993	0.007
W18 Other fall on same level	0.007	0.993	0.000
W10 Fall on and from stairs and steps	0.007	0.993	0.000
W08.0 Home	0.007	0.993	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.007	0.993	0.000
W03.8 Other specified place	0.007	0.993	0.000
W03.3 Sports and athletics area	0.007	0.993	0.000
W03.7 Farm	0.007	0.993	0.000
W03.6 Industrial and construction area	0.007	0.993	0.000
W03.5 Trade and service area	0.007	0.993	0.000
W03.4 Street and highway	0.007	0.993	0.000
W03.2 School, other institution and public administrative area	0.007	0.993	0.000
W03.1 Residential institution	0.007	0.993	0.000
S12.20 Fracture of other specified cervical vertebra (closed)	0.007	0.993	0.000
W75-W84 Other accidental threats to breathing	0.007	0.993	0.000
V95-V97 Air and space transport accidents	0.007	0.993	0.000
G53.8 Other cranial nerve disorders in other diseases classified elsewhere	0.000	0.993	0.007
G53.3 Multiple cranial nerve palsies in neoplastic disease	0.000	0.993	0.007
G53.2 Multiple cranial nerve palsies in sarcoidosis	0.000	0.993	0.007
G53.1 Multiple cranial nerve palsies in infectious and parasitic diseases classified elsewhere	0.000	0.993	0.007
W07.9 Unspecified place	0.007	0.993	0.000
M86-M90 Other osteopathies	0.007	0.993	0.000
W13 Fall from, out of or through building or structure	0.007	0.993	0.000
X20-X29 Contact with venomous animals and plants	0.007	0.993	0.000
Y35-Y36 Legal intervention and operations of war	0.007	0.993	0.000
X85-X99 Assault	0.007	0.993	0.000
X30-X39 Exposure to forces of nature	0.007	0.993	0.000
X00-X09 Exposure to smoke, fire and flames	0.007	0.993	0.000
W65-W74 Accidental drowning and submersion	0.007	0.993	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.007	0.993	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.007	0.993	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.007	0.993	0.000
C71.1 Frontal lobe	0.007	0.993	0.000
W08.9 Unspecified place	0.007	0.993	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.007	0.993	0.000
X50-X57 Overexertion, travel and privation	0.007	0.993	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.007	0.993	0.000
W17 Other fall from one level to another	0.007	0.993	0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.007	0.993	0.000
W06.1 Residential institution	0.006	0.993	0.000
V80-V89 Other land transport accidents	0.006	0.993	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.006	0.993	0.000
W00.9 Unspecified place	0.006	0.993	0.000
W00.8 Other specified place	0.006	0.993	0.000
W00.4 Street and highway	0.006	0.993	0.000
W00.0 Home	0.006	0.993	0.000
W00.7 Farm	0.006	0.993	0.000
W00.6 Industrial and construction area	0.006	0.993	0.000
W00.5 Trade and service area	0.006	0.993	0.000
W00.2 School, other institution and public administrative area	0.006	0.993	0.000
W00.1 Residential institution	0.006	0.993	0.000
M89.88 Other specified disorders of bone (Other)	0.006	0.994	0.000
Y43.3 Other antineoplastic drugs	0.006	0.994	0.000
Y28.9 Unspecified place	0.006	0.994	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.006	0.994	0.000
W08.8 Other specified place	0.006	0.994	0.000
W08.7 Farm	0.006	0.994	0.000
W08.6 Industrial and construction area	0.006	0.994	0.000
W08.5 Trade and service area	0.006	0.994	0.000
W08.4 Street and highway	0.006	0.994	0.000
W08.3 Sports and athletics area	0.006	0.994	0.000
W08.2 School, other institution and public administrative area	0.006	0.994	0.000
W08.1 Residential institution	0.006	0.994	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.006	0.994	0.000
W03.9 Unspecified place	0.006	0.994	0.000
M89.0 Algoneurodystrophy	0.006	0.994	0.000
W50-W64 Exposure to animate mechanical forces	0.006	0.994	0.000
S61.8 Open wound of other parts of wrist and hand	0.000	0.994	0.006
H94 Other disorders of ear in diseases classified elsewhere	0.006	0.994	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.006	0.994	0.000
C18.7 Sigmoid colon	0.006	0.994	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.006	0.994	0.000
W06.0 Home	0.006	0.994	0.000
M89.8 Other specified disorders of bone	0.006	0.994	0.000
V78 Bus occupant injured in noncollision transport accident	0.006	0.994	0.000
G58.8 Other specified mononeuropathies	0.000	0.994	0.006
W06.2 School, other institution and public administrative area	0.006	0.994	0.000
W06.8 Other specified place	0.006	0.994	0.000
W06.7 Farm	0.006	0.994	0.000
W06.6 Industrial and construction area	0.006	0.994	0.000
W06.5 Trade and service area	0.006	0.994	0.000
W06.4 Street and highway	0.006	0.994	0.000
W06.3 Sports and athletics area	0.006	0.994	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.006	0.994	0.000
V98-V99 Other and unspecified transport accidents	0.006	0.994	0.000
G59.8 Other mononeuropathies in diseases classified elsewhere	0.000	0.994	0.006
M89.5 Osteolysis	0.006	0.994	0.000
Y00 Assault by blunt object	0.006	0.994	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.006	0.994	0.000
G59.0 Diabetic mononeuropathy	0.000	0.994	0.006
S12.2 Fracture of other specified cervical vertebra	0.006	0.994	0.000
V01-V09 Pedestrian injured in transport accident	0.006	0.994	0.000
X62.9 Unspecified place	0.006	0.994	0.000
H90.5 Sensorineural hearing loss, unspecified	0.006	0.994	0.000
Y28.0 Home	0.006	0.994	0.000
M87 Osteonecrosis	0.006	0.994	0.000
V93 Accident on board watercraft without accident to watercraft, not causing drowning and submersion	0.006	0.994	0.000
Y34 Unspecified event, undetermined intent	0.006	0.994	0.000
Y33 Other specified events, undetermined intent	0.006	0.994	0.000
Y32 Crashing of motor vehicle, undetermined intent	0.006	0.994	0.000
Y31 Falling, lying or running before or into moving object, undetermined intent	0.006	0.994	0.000
Y30 Falling, jumping or pushed from a high place, undetermined intent	0.006	0.994	0.000
Y29 Contact with blunt object, undetermined intent	0.006	0.994	0.000
Y27 Contact with steam, hot vapours and hot objects, undetermined intent	0.006	0.994	0.000
Y26 Exposure to smoke, fire and flames, undetermined intent	0.006	0.994	0.000
Y25 Contact with explosive material, undetermined intent	0.006	0.994	0.000
Y24 Other and unspecified firearm discharge, undetermined intent	0.006	0.994	0.000
Y23 Rifle, shotgun and larger firearm discharge, undetermined intent	0.006	0.994	0.000
Y22 Handgun discharge, undetermined intent	0.006	0.994	0.000
Y21 Drowning and submersion, undetermined intent	0.006	0.994	0.000
Y20 Hanging, strangulation and suffocation, undetermined intent	0.006	0.994	0.000
Y19 Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent	0.006	0.994	0.000
Y18 Poisoning by and exposure to pesticides, undetermined intent	0.006	0.994	0.000
Y17 Poisoning by and exposure to other gases and vapours, undetermined intent	0.006	0.994	0.000
Y16 Poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours, undetermined intent	0.006	0.994	0.000
Y15 Poisoning by and exposure to alcohol, undetermined intent	0.006	0.994	0.000
Y14 Poisoning by and exposure to other and unspecified drugs, medicaments and biological substances, undetermined intent	0.006	0.994	0.000
Y13 Poisoning by and exposure to other drugs acting on the autonomic nervous system, undetermined intent	0.006	0.994	0.000
Y12 Poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified, undetermined intent	0.006	0.994	0.000
Y11 Poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified, undetermined intent	0.006	0.994	0.000
Y10 Poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, undetermined intent	0.006	0.994	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations